Brief: ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
22/10/2025 12:32
Oct 22 (Reuters) - Prophase Labs Inc PRPH.O: PROPHASE LABS ANNOUNCES STUDY VALIDATING BE-SMART ESOPHAGEAL CANCER TEST ACCEPTED BY JOURNAL OF CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Source text: ID:nGNX4XmgCx Further company coverage: PRPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prophase Labs
See all newsBrief: Prophase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:29 PM